These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32860320)

  • 1. Assessment of Neisseria gonorrhea prevalence and resistance in the Eastern Mediterranean Region.
    Maatouk I; Assi M
    Dermatol Ther; 2020 Nov; 33(6):e14241. PubMed ID: 32860320
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic-resistant
    Wall KM; Nyombayire J; Parker R; Ingabire R; Bizimana J; Mukamuyango J; Mazzei A; Price MA; Unyuzimana MA; Tichacek A; Allen S; Karita E
    Int J STD AIDS; 2022 Mar; 33(3):315-317. PubMed ID: 34879755
    [No Abstract]   [Full Text] [Related]  

  • 3. What management is there for gonorrhea in the postquinolone era?
    Tapsall JW
    Sex Transm Dis; 2006 Jan; 33(1):8-10. PubMed ID: 16385215
    [No Abstract]   [Full Text] [Related]  

  • 4. Neisseria gonorrhoeae - Rising Infection Rates, Dwindling Treatment Options.
    Blank S; Daskalakis DC
    N Engl J Med; 2018 Nov; 379(19):1795-1797. PubMed ID: 30403946
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
    Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
    J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
    Chan DJ; Tapsall J
    Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sharp increase in ciprofloxacin resistance of
    Crucitti T; Belinga S; Fonkoua MC; Abanda M; Mbanzouen W; Sokeng E; Nzouankeu A
    Int J STD AIDS; 2020 May; 31(6):579-586. PubMed ID: 32316853
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of gonorrhea].
    Müller P; Müller T; Storck H
    Ther Umsch; 1969 Feb; 26(2):75-80. PubMed ID: 4977041
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic-Sparing Gonorrhea Diagnostic Wins Federal Funding.
    Abbasi J
    JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897327
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.
    Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD
    BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina.
    Gianecini R; Oviedo C; Stafforini G; Galarza P
    Emerg Infect Dis; 2016 Jun; 22(6):1139-41. PubMed ID: 27191699
    [No Abstract]   [Full Text] [Related]  

  • 12. Gonorrhea in Indonesia: High Prevalence of Asymptomatic Urogenital Gonorrhea but No Circulating Extended Spectrum Cephalosporins-Resistant Neisseria gonorrhoeae Strains in Jakarta, Yogyakarta, and Denpasar, Indonesia.
    Hananta IP; van Dam AP; Bruisten SM; Schim van der Loeff MF; Soebono H; de Vries HJ
    Sex Transm Dis; 2016 Oct; 43(10):608-16. PubMed ID: 27626188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it time to reconsider epidemiological treatment for gonorrhoea?
    Mensforth S; Radcliffe K
    Int J STD AIDS; 2018 Sep; 29(10):1043-1044. PubMed ID: 30198837
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-resistant Neisseria gonorrhoeae: latest developments.
    Suay-García B; Pérez-Gracia MT
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1065-1071. PubMed ID: 28210887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on various
    Mullick JB; Majumdar T; Bir R; Hore S; Sil SK
    Indian J Dermatol Venereol Leprol; 2017; 83(4):499-501. PubMed ID: 28540875
    [No Abstract]   [Full Text] [Related]  

  • 16. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(16):335-8. PubMed ID: 15123985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of porA pseudogene deletion among Neisseria gonorrhoeae isolates referred to the UK's Gonococcal Resistance to Antimicrobials Surveillance Program.
    Toby M; Saunders P; Cole M; Grigorjev V; Alexander S; Ison C
    Sex Health; 2017 Aug; 14(4):392-393. PubMed ID: 28514990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neisseria gonorrhoeae infections].
    Furuya R; Tanaka M
    Nihon Rinsho; 2009 Jan; 67(1):129-35. PubMed ID: 19177762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects of untreatable gonorrhea and ways forward.
    Whiley DM; Lahra MM; Unemo M
    Future Microbiol; 2015; 10(3):313-6. PubMed ID: 25812453
    [No Abstract]   [Full Text] [Related]  

  • 20. CDC update on gonorrhea: expand treatment to limit resistance.
    Campos-Outcalt D
    J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.